Skip to main content

Table 1 Baseline characteristics

From: Optimal timing of primaquine to reduce Plasmodium falciparum gametocyte carriage when co-administered with artemether–lumefantrine

Characteristics

Treatment arm

p-value

AL only (n = 33)

AL + primaquine day 1 (n = 37)

AL + primaquine day 3 (n = 37)

Male sex (%)

17 (51.5)

20 (54.1)

15 (40.5)

0.469

Mean age (SD; range)

8.5 (4.0; 3–17)

7.9 (3.2; 3–16)

7.5 (3.9; 3–17)

0.365

Mean haemoglobin (SD; range)

11.1 (1.2; 9–14)

10.9 (1.6; 9.1–13.8)

10.2 (1.2; 8.7–13.9)

0.441

Mean parasitaemia density (SD; range)

413.3 (596.0; 29–3205)

433.7 (354.7; 28–1116)

349 (317.4; 28–1030)

0.424

  1. AL artemether–lumefantrine, SD standard deviation